Home
Vernal Biosciences, Inc.

Vernal Biosciences, Inc. Market Share Analysis for June 2026

Vernal Biosciences is an mRNA CDMO delivering high-purity mRNA manufacturing, LNP formulation, and GMP support for vaccines, gene therapies, and mRNA therapeutics.

Industry: N/A

Domainvernal.bio

Year Founded2020

Employees51 - 200

Annual Revenue$2M - $5M

Vernal Biosciences, Inc.

Vernal Biosciences, Inc. (including company regionals)

vernal.bio

See more website traffic and engagement information

Vernal Biosciences, Inc. Revenue up to June 2026 is 2M - 5M

revenue generated by Vernal Biosciences, Inc. top domains

Vernal Biosciences, Inc. top domains revenue over 3 years

Revenue for Vernal Biosciences, Inc. top domains

vernal.bio2M - 5M

See more with Sales Intelligence

Total visits to Vernal Biosciences, Inc.'s top domains

Understand Vernal Biosciences, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vernal.bio2.2K

See more with Sales Intelligence

Avg. visit duration in Vernal Biosciences, Inc.'s top domains

Analyze Vernal Biosciences, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

vernal.bio00:00:38

See more with Sales Intelligence

Avg. pageviews on Vernal Biosciences, Inc.'s top domains

See how Vernal Biosciences, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vernal.bio1.72

See more with Sales Intelligence

Vernal Biosciences, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Vernal Biosciences, Inc.

These are the website technologies, by industry, used by Vernal Biosciences, Inc. top domains

Advertising (5)

DoubleClick

Marketing (3)

Google Marketing Platform

Widget (3)

reCAPTCHA

Content Management System (2)

WordPress

More Technologies

10

See all

News & Signals from Vernal Biosciences, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRepair Biotechnologies, Inc. partners with Vernal Biosciences.By partnering with Vernal, Repair reduced the friction around on-time supply of mRNA for critical preclinical studies.

NewsVernal Biosciences hired Jim Petrilla as Chief Executive Officer (CEO) and Board Director on Oct 31st '24.Vernal Biosciences Inc., a leader in mRNA and lipid nanoparticle (LNP) development, manufacturing, and analytics, today announces the appointment of Jim Petrilla as Chief Executive Officer (CEO) and Board Director.

NewsVernal Biosciences hires Sven Lee as Chief Commercial Officer.COLCHESTER, Vt.-(BUSINESS WIRE)-Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, and Richard P. Hamel, Chief Financial Officer to its leadership team.